Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Insulet Corp. Stock

Price
Target price
€162.10

€162.10

0.250%
0.4
0.250%
€215.54

€215.54

 
Buy 14 Sell 0
Buy 14
Sell 0
03.05.24 / Tradegate WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Latest predictions
13.04.24
-2.50%
buy
€212.43
23.02.24
-4.76%
buy
€207.81
23.02.24
-4.76%
buy
€213.00
22.02.24
-4.65%
buy
€216.46
21.12.23
-16.25%
buy
€215.54
04.12.23
-10.27%
buy
Show more
Best running prediction
€174.43
16.10.23
26.34%
buy
Your prediction
Pros and Cons of Insulet Corp. in the next few years
Wizard

Insulet Corp. Stock

Insulet Corp. gained 0.250% compared to yesterday.
Insulet Corp. is currently one of the favorites of our community with 14 Buy predictions and no Sell predictions.
With a target price of 215 € there is a positive potential of 32.63% for Insulet Corp. compared to the current price of 162.1 €.
What does Insulet do?

Pros and Cons of Insulet Corp. in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Insulet Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Insulet Corp. 0.250% 5.913% 6.505% -44.200% -18.317% -30.697% -
Neogen Corp. -0.880% 2.727% -14.394% -25.658% -38.251% -71.750% -58.063%
Bio-Rad Labs Inc. A 0.870% 0.970% -14.121% -38.053% -11.342% -48.961% -
Merit Medical Systems 1.440% 2.174% 5.224% -3.425% 3.676% 34.286% 39.742%

Comments

Prediction Buy
Perf. (%) -4.76%
Target price 212.428
Change
Ends at 23.02.25

Insulet Co. (NASDAQ: PODD) had its price target lowered by analysts at Piper Sandler from $250.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Show more

Piper Sandler 
0
Report Share
23.02.24
Prediction Buy
Perf. (%) -4.76%
Target price 207.810
Change
Ends at 23.02.25

Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $225.00. They now have an "overweight" rating on the stock.
Ratings data for PODD provided by MarketBeat
Show more

JPMorgan Chase & Co. 
0
Report Share
23.02.24
Prediction Buy
Perf. (%) -16.25%
Target price 216.461
Change
Ends at 21.12.24

Insulet Co. (NASDAQ: PODD) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $238.00 price target on the stock, up previously from $180.00.
Ratings data for PODD provided by MarketBeat
Show more

Robert W. Baird 
0
Report Share
21.12.23
Show more
Not a member yet? Sign up for free!

News

HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg
HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back. 

Investors

MarketBeat 
0 08.01.24